Article info

Download PDFPDF

Using clinically stable disease (NEDA 2) as a proxy for disease impact and employment in MS paints an incomplete picture

Authors

  1. Correspondence to Sharon Roman, Vancouver, British Columbia, Canada; slhroman{at}gmail.com
View Full Text

Citation

Roman S
Using clinically stable disease (NEDA 2) as a proxy for disease impact and employment in MS paints an incomplete picture

Publication history

  • Received September 9, 2019
  • Accepted September 14, 2019
  • First published November 14, 2019.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.